ArticleFrontiers in oncology2023
Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases.
Mohammed Abdulhaleem et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it